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Abstract: Enzyme catalyzed reactions are complex reactions due to the interplay of the enzyme,
the reactants, and the operating conditions. To handle this complexity systematically and make
use of a design space without technical restrictions, we apply the model based approach of
elementary process functions (EPF) for selecting the best process design for enzyme catalysis
problems. As a representative case study, we consider the carboligation of propanal and
benzaldehyde catalyzed by benzaldehyde lyase from Pseudomonas fluorescens (Pf BAL) to produce
(R)-2-hydroxy-1-phenylbutan-1-one, because of the substrate dependent reaction rates and the
challenging substrate dependent Pf BAL inactivation. The apparatus independent EPF concept
optimizes the material fluxes influencing the enzyme catalyzed reaction for the given process
intensification scenarios. The final product concentration is improved by 13% with the optimized
feeding rates, and the optimization results are verified experimentally. In general, the rigorous model
driven approach could lead to selecting the best existing reactor, designing novel reactors for enzyme
catalysis, and combining protein engineering and process systems engineering concepts.
Keywords: enzyme catalysis; optimal design; process intensification; elementary process functions;
benzaldehyde lyase; 2-hydroxy ketones
1. Introduction
The pharmaceutical industry is considering biocatalytic processes as a possible alternative to
chemocatalytic processes [1–3]. This is primarily due to the high stereoselectivity and specificity
of biocatalytic processes, which lead to efficient production of high-quality active pharmaceutical
ingredients (APIs) in fewer synthesis steps [2,3]. Less complex synthesis is of economic importance
to the pharmaceutical industry as it could translate into cost savings and greener pharmaceutical
processes [3]. In recent years, the design of biocatalysts for the efficient synthesis of APIs has witnessed
significant advancements [1].
To render enzyme processes economically viable, a high product concentration and low enzyme
cost must be ensured [2]. To this end, the advancements in protein engineering [1], appropriate reaction
engineering concepts [4], and process intensification strategies must be combined [5,6]. A traditional
method for performing this optimization is by carrying out numerous experiments in the lab that are
cost and time intensive. Therefore, computer aided model based approaches have been proposed to
complement laboratory experiments [7,8]. As examples of the application of model based approaches to
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optimize enzyme catalyzed reactions, Stillger et al. developed an enzyme-membrane continuous stirred
tank reactor (CSTR) for the carboligation of benzaldehyde and acetaldehyde catalyzed by benzaldehyde
lyase from Pseudomonas fluorescens (Pf BAL) to produce (R)-2-hydroxy-1-phenylpropanone (HPP) [9].
In their work, they performed simulations by using a kinetic model in combination with reactor models
to select the best performing reactor. Parallel to this work, Hildebrand et al. [10] investigated the
production of HPP by Pf BAL in a membrane CSTR using a kinetic model to simulate different reaction
engineering strategies to select the best reactor design. In their work, however, Pf BA inactivation
was observed, but was not included in the kinetic model and, thus, could neither be predicted nor
simulated [10]. Begemann et al. used a model based approach to analyze reactors and develop a
control strategy for a two phase biocatalytic oxidoreduction system catalyzed by Candida parapsilosis
carbonyl reductase 2 [11]. Based on simulations of their model, they showed that a fed-batch reactor
performed better than a batch reactor for the chosen reaction. Their simulations also showed that
controlling the pH could increase conversions and improve productivity. By performing simulations
with coupled kinetic models and reactor design equations, Braun et al. minimized the enzyme costs for
the biocatalytic production of 12-ketochenodeoxycholic acid in a batch reactor [7]. Marpani et al. [12]
utilized a kinetic model and simulation approach to determine the optimal operating conditions for
the biocatalytic conversion of formaldehyde to methanol in a batch reactor. Although their work
showed excellent agreement between the simulation and experimental results, it involved performing
hundreds of simulations [12].
Therefore, even simulation based approaches might be time consuming and could lead to
sub-optimal results [13]. Furthermore, there is no guarantee that the design space explored by the
simulations would lead to optimal results. Fortunately, model based process optimization methods
have been established in process systems engineering, which could lead to (at least locally) guaranteed
optimal reactor designs and operating conditions. Furthermore, most existing model based reactor
design approaches for enzyme catalysis are based on comparing a limited subset of existing reactor
types, which constrains the design space and limits the possibilities of designing novel intensified
reactors for enzyme catalysis.
In the last decade, a model based reactor design approach that is based on the concept of
elementary process functions (EPF) was proposed by Freund and Sundmacher. The basic premise
of the EPF concept is to design reactors based on their essential reaction functions rather than
optimizing predefined apparatuses or equipment [14] and, therefore, to formulate the reactor design
problem as a reaction function optimization problem. To describe and optimize processes with the
EPF approach, a fluid element is considered traveling through the thermodynamic state space of a
(bio)chemical reaction that is acted upon by internal and external mass and energy fluxes. These fluxes
are then designed to drive the fluid element to the desired state in the thermodynamic state space,
thus maximizing a particular objective function or performance metric, such as the final product
concentration, space-time yield, or total enzyme turnover number. Material and energy balances of
the fluid element are set up from first principles to model the fluid element. They are accompanied
by detailed reaction kinetics and thermodynamic relations, which explain the key phenomena taking
place within and outside the fluid element.
Given that the fluid element changes with time, a dynamic optimization problem is formulated
by using the balances, reaction kinetic and thermodynamic equations, and constraints that are inherent
to the particular process. The dynamic optimization problem is then solved for different intensification
cases. Based on the corresponding simulations, the best intensification strategy is selected and
then technically approximated by using an off-the-shelf reactor or by designing a novel reactor to
approximate the optimal fluxes obtained [15]. The EPF approach has been applied extensively to select
the best existing reactor or to design novel reactors for the optimal production of bulk chemicals [16–21].
Recently, we worked on extending the EPF approach to biotechnological processes [22,23]. In this
paper, we build on our previous work by presenting a clear guideline for applying the EPF approach
to enzyme catalysis.
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The objective of this paper is to implement and experimentally demonstrate the applicability
of the EPF approach for enzyme catalysis problems. As a case study, we chose the Pf BAL
catalyzed carboligation of propanal and benzaldehyde to form (R)-2-hydroxy-1-phenylbutan-1-one,
which is representative of biocatalytic carboligations to optically pure 2-hydroxy ketones,
key organic intermediates for producing a vast array of APIs [9,10,24]. The Pf BAL catalyzed
conversion of benzaldehyde in the presence of propanal can, in theory, yield four different
enantiopure compounds [25]: the two asymmetric products (R)-2-hydroxy-1-phenylbutan-1-one
and (R)-1-hydroxy-1-phenylbutan-2-one, as well as the two symmetric products (R)-benzoin and
(R)-propioin. However, in the case of Pf BAL catalyzed carboligation, the aromatic substrate
benzaldehyde is preferred as the donor molecule over the aliphatic aldehyde propanal, thus eliminating
two of the possible products [26]. In Figure 1, we show the corresponding reaction system, adapted
from Ohs et al. [27].
E E-B
E-B-B
E-B-A
E
k1 k11
k2 k22
k3 k33
E
k4 k44
k5 k55
Benzaldehyde
(B)
(R)-Benzoin
(BB)
Propanal
(A)
(R)-2-Hydroxy-1-phenylbutan-1-one
(BA)
Figure 1. Branched reaction scheme for benzaldehyde lyase from Pseudomonas fluorescens (Pf BAL)
catalyzed carboligations with benzaldehyde and propanal as substrates.
The simplified network can be described as three coupled reaction pathways. In the first step,
benzaldehyde (B) forms a covalent bond with the ThDP cofactor in the Pf BAL (E) active site. Starting
from this first intermediate, the pathway branches into two separate reactions depending on the
second substrate: self-carboligation occurs if a second benzaldehyde molecule binds to the enzyme,
acting as an acceptor molecule. The resulting (R)-benzoin (BB) is regarded as a side product in this
study. In the cross-carboligation, propanal (A) acts as the acceptor substrate, leading to the desired
product (R)-2-hydroxy-1-phenylbutan-1-one (BA). The self-carboligation and the cross-carboligation
are modeled as ordered bi-uni-reaction mechanisms. The third reaction pathway describes the transfer
reaction between the two carboligation products and is modeled as a ping-pong-bi-bi mechanism.
Because the reaction rate and Pf BAL inactivation depend on the substrate concentration [27],
the objective is to maximize the final concentration of (R)-2-hydroxy-1-phenylbutan-1-one by tuning
the fluxes due to substrate feeding. To our knowledge, this work constitutes the first study that designs
and experimentally reproduces an optimal enzyme catalyzed carboligation using the model based EPF
approach with a kinetic considering enzyme inactivation.
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2. Results and Discussion
Following the EPF strategy, three intensification cases were investigated systematically to
ascertain the best process intensification scenario for the maximization of the final concentration
of (R)-2-hydroxy-1-phenylbutan-1-one produced from the Pf BAL catalyzed carboligation between
propanal and benzaldehyde. A batch reactor was selected as the reference case because it is the most
common reactor used for enzyme catalyzed reactions. Due to the rapid enzyme inactivation caused
by the substrates (propanal and benzaldehyde), it was hypothesized that dosing concepts could be
advantageous over the batch reactor resulting in the following case studies.
Case 1: Dosing of propanal. In this case, the propanal dosing flux was incorporated into the
material balance and dynamically optimized. In addition to the dosing flux of propanal, the initial
volume and the optimal initial concentrations of propanal and benzaldehyde required for the
highest possible concentration of (R)-2-hydroxy-1-phenylbutan-1-one were degrees-of-freedom in
the optimization.
Case 2: Dosing of benzaldehyde. In a similar fashion to Case 1, the dosing of only benzaldehyde
along the reaction coordinate was investigated. The dosing rate of benzaldehyde, the initial volume,
and initial concentrations of propanal and benzaldehyde were optimized with the same goal of
maximizing the final concentration of the target product.
Case 3: Dosing of propanal and benzaldehyde. In Case 3, all tunable operating conditions were
optimized for maximizing the cross-carboligation product concentration, namely the dynamic dosing
fluxes of the reactants propanal and benzaldehyde, as well as the initial concentrations of the substrates
and the enzyme.
In the subsequent sections, experimental data are presented for the reference case to confirm
the validity of the kinetic model derived previously and for the predicted best intensification
scenario. However, to carry out the model based optimization, a mathematical model of the
underlying reaction phenomena that includes material and energy fluxes is required first. Note that
in this study, energy balances are not considered, due to the mild conditions at which the Pf BAL
catalyzed carboligation is performed and the assumption that these conditions are not energy
intensive [2,3]. Only material balances that follow the so-called Lagrangian formulation [15] are
considered. The essential terms in these balances are the reaction rate expressions, which are defined
by a kinetic model in Section 3.1.2.
2.1. Reference Case: Batch Reactor
The concentration profiles of the optimized batch reactor are shown in Figure 2a-i, including the
concentration progress of the respective experimental data. For better readability, concentrations of
A and E are displayed on the second y-axis and indicated by arrows, and the concentration of active
enzyme in the system has been shortened to “enzyme concentration”.
The optimized initial concentrations for A and E of 100 mmol L−1 and 50 µg mL−1, respectively,
are restricted by the upper bounds, whereas that of B of 5.94 mmol L−1 is not (Table 1). The optimization
result is because the BA product formation rate is proportional to E and approximately proportional
to A and B (Equations (14)–(16)). Note that the enzyme is inactivated much more strongly by
benzaldehyde than by propanal, corresponding to the 15 fold higher inactivation rate parameters
(Table 2). Due to the increased reaction rate towards BA and the lower inactivation rate parameter
of A, a large excess concentration of the aliphatic compound compared to benzaldehyde seemed
beneficial for the investigated objective function. The simulated final concentration of the active
enzyme reached 1.08 µg mL−1, indicating nearly full enzyme inactivation of 97.8 % over the 180 min
reaction time. The simulated optimal final BA concentration of 5.83 mmol L−1 together with the
final propanal and benzaldehyde concentrations of 94.17 mmol L−1 and 0.11 mmol L−1, respectively,
showed that propanal and benzaldehyde were converted quantitatively, with a conversion of over 98 %
for the limiting substrate benzaldehyde and eliminating benzoin byproduct formation at the reaction
endpoint after 180 min.
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Table 1. Summary of the optimization results: initial concentrations Ci(t0), final concentrations Ci(t f ),
solution time for the reference case and the three process intensification scenarios, as well as the residual
sum of squares (RSS) and mean squared error (MSE) for the experimental validations.
Ref. Case Case 1 Case 2 Case 3
CA(t0) mmol L−1 100 100 100 100
CB(t0) mmol L−1 5.94 6.00 0.71 0.70
CE(t0) µg mL−1 50 50 50 50
sA(Dosing of A) - 0 1 0 1
sB(Dosing of B) - 0 0 1 1
CBA(t f ) mmol L−1 5.83 5.88 6.52 6.59
CE(t f ) µg mL−1 1.08 0.95 1.26 1.08
RSS mmol2 L−2 2.51 - - 3.22
MSE mmol2 L−2 0.05 - - 0.06
Solution time s 1.4 2.6 2.5 3.8
Table 2. Kinetic parameters for the Pf BAL kinetic model.
Rate Constant Unit Value
k1 mmol−1L min−1 6184
k11 min−1 93.2
k2 mmol−1L min−1 68,621
k22 min−1 7,294,883
k3 min−1 15,955
k33 mmol−1L min−1 26,158
k4 mmol−1L min−1 1.83
k44 min−1 0.00190
k5 min−1 41,610
k55 mmol−1L min−1 373
kinact,A mmol−1L min−1 0.000157
kinact,B mmol−1L min−1 0.00246
kinact,time min−1 0.00400
The initial decrease rate of B was higher than that of A for the first 7 min of the reaction,
which coincided with the rapid formation of byproduct benzoin (BB) (Figure 2a-ii). These initial rates
could be attributed to the higher affinity of the enzyme at the acceptor position to benzaldehyde over
propanal [26]. The byproduct benzoin (BB) concentration peak indicated that the net BB formation rate
equaled zero and may be explained by the enzyme specificity in the donor position, which was highest
for BB (Pf BAL has been discovered as lyase [28]) followed by the aromatic benzaldehyde (B). In contrast,
the aliphatic propanal was practically not accepted as the substrate in the presence of aromatic
compounds. The rate of AB formation exactly mirrored that of A consumption. The experimental data
successfully confirmed the predicted model optimum, although minor discrepancies could be observed;
see Figure 2a-i. The experimentally determined initial concentrations of B amounted to 6.23 mmol L−1
instead of the optimal value of 5.94 mmol L−1. The deviation in the initial concentrations, in turn,
led to an initially higher concentration of the byproduct BB during the first 30 min of the reaction
time. Up to around 60 min of the reaction time, the measured concentrations of substrate B and
product BA were nearly superimposable with the simulation results, but dropped below the predicted
values afterward. In addition, the mass balance with respect to B represented in the sum of B,
BA, and two times BB was not closed over the reaction period, but instead declined slightly due
to evaporation to finally reach 5.47 mmol L−1 or a loss of 11 %. The same evaporation loss also
applied to Compound A, which, however, was assumed to have a negligible impact on the progress
curves due to its high stoichiometric excess. However, the conversion of B to BA after the full
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reaction time matched the simulation. It is important to note the excellent quality of the optimization
prediction to the experimental reproducibility run, in particular given that the kinetic model was
obtained using a separate set of experimental data [27] and partially obtained in a different lab using
different instrumentation.
(a) Reference batch case
0 30 60 90 120 150 180
0
2
4
6
Time / min
Co
nc
en
tra
tio
n
/
m
m
ol
L−
1
0
20
40
60
80
100
Pr
op
an
al
(A
)c
on
ce
nt
ra
tio
n
/
m
m
ol
L−
1
En
zy
m
e
(E
)c
on
ce
nt
ra
tio
n
/
µg
m
L−
1
B
BA
BB
A
E
B (exp)
BA (exp)
BB (exp)
(a-i)
(b) Case 1: Dosing of A
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(c) Case 2: Dosing of B
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(d) Case 3: Dosing of A and B
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Figure 2. Results of the dynamic optimization and their experimental verification. Columns: (a) Batch
reference, (b) Intensification Case 1 involving the dosing of A, (c) Intensification Case 2 involving the
dosing of B, and (d) Intensification Case 3 involving the dosing of A and B. Rows: (i) concentration
profiles, (ii) reaction rate profiles, and (iii) volumetric flow rate profiles. Starting concentrations within
the design space were optimized so that the concentration of BA at final time point t f = 180 min
was maximized. Lower concentration bounds were defined as 0 mmol L−1 and upper bounds as 100,
149.35, 2.78 mmol L−1, and 50 µg mL−1 for A, B, BB, and E, respectively. Experiments were conducted
at 30 ◦C in a reaction volume of 30 mL (70 % v/v TEA buffer with cofactors and 30 % v/v DMSO)
at pH = 8.5. Batch reference: CBA,sim(t f ) = 5.83 mmol L−1, CBA,exp(t f ) = 5.40 mmol L−1, Case 3:
CBA,sim(t f ) = 6.59 mmol L−1, CBA,exp(t f ) = 6.97 mmol L−1.
In summary, optimizing the batch case for a maximum concentration of BA led to nearly full
conversion of B with selectivity to the target compound of over 98%, albeit at the cost of almost
complete enzyme inactivation.
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2.2. Case 1: Dosing of Propanal
The optimization of the dosing of propanal (A) along the reaction coordinate led to a slightly
higher allowable initial concentration of B of 6 mmol L−1 (those of E and A were again restricted by
their upper bounds) and a slightly higher final BA concentration of 5.88 mmol L−1 at comparable
98 % conversion (Table 1). The concentration profile of reactant A remained at a constant value of
100 mmol L−1 throughout the course of the reaction (Figure 2b-i), which was given by the upper
bound defined in Equation (17j). The constant propanal concentration was achieved by a decreasing
propanal dosing rate along the reaction coordinate (Figure 2b-iii), which followed its consumption
rate (Figure 2b-ii). The maintained optimal concentration of A showed that an increased reaction rate
toward BA outweighed the enzyme inactivation caused by A. Note that setting the upper bound to a
higher value beyond the design space limit used in this study might further increase the concentration
of BA. Except for the concentration of A, all other concentration and reaction rate profiles resembled
those of the reference batch case (Figure 2a-i,a-ii). In summary, the only marginal increase in the final
concentration of BA for this case was essentially due to the constant concentration of A, but suggested
that the added experimental effort for the intensification was probably not warranted.
2.3. Case 2: Dosing of Benzaldehyde
In the case of dosing benzaldehyde (B) (Figure 2c-i), the optimal initial concentration of B was
reduced by nearly an order of magnitude to 0.71 mmol L−1 with A and E being restricted by their
upper bounds. The concentration profile for A resembled that of the reference batch case. A final BA
concentration of 6.52 mmol L−1 was obtained (Table 1), which corresponded to a 12 % increase over
the batch reference.
In Figure 2c-i, we show that the concentration of B was maintained at a relatively constant
low concentration. Similar to the propanal dosing case, the almost constant concentration of B
was achieved by the dosing profile (Figure 2c-iii) mirroring the benzaldehyde consumption rate
(Figure 2c-ii). However, the low B concentration drove the cross-carboligation pathway to maximize
the formation of BA while the competing side product BB was formed at a relatively low concentration.
In Figure 2c-ii, we highlight this effect, as the reaction rate of BB stays close to zero after a very
short initial formation phase. The consumption rates of A and B nearly overlapped, which further
supported the assumption that the optimal dosing of A shifted the reaction network significantly
toward the conversion of A and B to form the target compound BA. However, the low concentration
of B minimized the inactivation of the enzyme due to B, resulting in a significantly reduced enzyme
inactivation rate (Figure 2c-ii), which was accompanied by a less steep enzyme activity loss than in
the reference batch case (Figure 2a-i) and Case 1 (Figure 2b-i). As a result, a higher concentration of
active enzyme was available for the production of BA at any time point. The low concentration of B at
each time point, therefore, yielded the optimal balance between reaction kinetics toward BA and the
conservation of Pf BAL.
2.4. Case 3: Dosing of Propanal and Benzaldehyde
The results for the case of dosing propanal (A) and benzaldehyde (B) simultaneously are shown
in Figure 2d-i. The optimal initial concentration of B of 0.70 mmol L−1 was only slightly lower than on
dosing of benzaldehyde and led to a final BA concentration of 6.59 mmol L−1 (Table 1) with a yield
of 88 %. This product concentration corresponded to a 13 % increase over the batch reference case
and was only slightly higher than the value obtained for Case 2, thus confirming that dosing of B
played an essential role in maximizing the final concentration of BA.
The dosing of A and B in Case 3 could be considered as a superposition of Case 1 and Case 2.
Thus, the discussions for Cases 1 and 2 also apply here. Dosing of A and B simultaneously led to the
highest final BA concentration from the intensification cases. Therefore, dosing of propanal (A) and
benzaldehyde (B) was the best intensification strategy among all cases considered in this work and
Catalysts 2020, 10, 96 9 of 17
was selected for experimental reproducibility. The experimental setup was technically approximated
as a fed-batch reactor.
In Figure 2d-i, we show the overlay of the simulated concentration progress for the optimized
initial conditions and feeding profiles with the experimental data, which confirmed the optimization
results. The measured concentration of BA nearly perfectly overlayed with the simulation for
approximately 120 min and then slightly diverged to higher values by up to 6 %. As the measured
initial concentrations were in line with the optimization case, but more benzaldehyde substrate was
converted toward the end of the experiment compared to the model prediction, slower enzyme
inactivation in the real experiment than in the predicted model seemed a plausible cause for this
deviation. Measured concentrations of BB stayed constantly below 0.1 mmol L−1, which was in line
with the simulation. The high ratio of BA to BB also confirmed the optimization result that keeping
concentrations of B low during the experiment increased the selectivity toward BA and slowed down
enzyme inactivation.
In contrast to the progress of BA and BB, the experimental concentration progress of B varied
over time, presumably due to the manual sample withdrawal. Although the outlet of the dosing
tube was submerged in the reaction solution, non-ideal mixing may have led to increased substrate
concentrations near the tube outlet. For the products BA and BB, this issue did not apply as these
compounds were homogeneously produced in the liquid body. An additional source of experimental
error might exist due to HPLC sample storage in slightly variable vials, where the volatile substrate B
may evaporate to the headspace, whereas BA and BB have low vapor pressures at ambient conditions.
In summary, the initial concentrations and feed rates obtained from the model based optimization
applied to the laboratory setup could be experimentally reproduced and led to an enhanced final BA
concentration, thus demonstrating successfully that the concentration of BA after a total runtime of
180 min could be increased by switching from the optimal batch scenario to an optimized fed-batch
setup with time dependent feeding rates of Substrates A and B.
2.5. Data Summary
The optimized initial substrate and enzyme concentrations, together with the predicted final
BA concentration and solution times for all cases, as well as the residual sum of squares and mean
squared error for the experimental validations are summarized in Table 1. The solution times for all
cases computed were between 1 and 4 s and, thus, orders of magnitude faster than the time required to
perform laboratory experiments. As laboratory experiments successfully validated the model based
predictions, they could significantly reduce the time for the development of enzymatic processes.
The model based prediction quality surpassed the typical results of response-surface-model
optimization using statistical experimental design. Thus, this study bolsters the importance and
justifies the effort to identify the proper mechanistically based kinetic model.
3. Materials and Methods
3.1. Computational Methods
3.1.1. Material Balances
The dynamic model consisted of the material balances for Species A, B, BA, BB, and E. Instead
of using the mole balances, as typically done in the EPF approach, we used a concentration
basis because of numerical robustness during optimization. Furthermore, a perfectly mixed fluid
element was assumed to avoid additional complexity introduced by the residence time distribution.
The corresponding mass balances for the reactants A and B are as follows:
dCA
dt
=
jA
V
− CA
V
(sAqA + sBqB) + rA , (1)
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dCB
dt
=
jB
V
− CB
V
(sAqA + sBqB) + rB , (2)
where:
jA = sAqACinA , (3)
jB = sBqBCinB , (4)
and where CA and CB denote the concentrations of propanal (A) and benzaldehyde (B) in the reactor,
respectively; j, q, and r the corresponding fluxes, feeding rates, and reaction rates, respectively; whereas
CinA and C
in
B denote the inlet feed concentrations of pure liquid propanal and benzaldehyde of 13.946 M
and 9.8 M, respectively. To avoid redundancy and provide a generalized representation of the material
balances for all cases considered in this work, the binary terms sA and sB were introduced. That is,
the reference batch case and dosing of either A and B were modeled via the binary decision variables,
sA and sB. For example, the material balance equations for the reference batch case could be obtained
by setting sA = 0 and sB = 0. Moreover, note that the variables CA, CB, jA, jB, qA, qB, and V were
all time varying, but for the sake of readability, the time varying argument was omitted. This also
holds for variables CBA, CBB, and CE in the following paragraphs. Similarly, the material balances for
the products (R)-2-hydroxy-1-phenylbutan-1-one (BA) and benzoin (BB), and the enzyme Pf BAL (E),
where no dosing occurs, are defined as:
dCBA
dt
= −CBA
V
(sAqA + sBqB) + rBA , (5)
dCBB
dt
= −CBB
V
(sAqA + sBqB) + rBB , (6)
dCE
dt
= −CE
V
(sAqA + sBqB) + rE . (7)
Finally, the change in volume with time due to the amount of A and B added during the reaction
is defined as follows:
dV
dt
= sAqA + sBqB. (8)
3.1.2. Mechanistic Kinetic Model
The mechanistic kinetic model was based on the reaction mechanism shown in Figure 1 and was
derived by solving the mass balances for substrates, products, and enzyme species under steady state
conditions for the enzyme intermediates. Furthermore, the model considered the rate of inactivation of
Pf BAL, which was derived previously by combining progress curve analysis and optimal experimental
design [27]. In this work, we additionally considered thermal deactivation of the enzyme, described
by the reaction rate constant kinact,time. The mechanistic kinetic model is given by:
rA = −NBAD · CE (9)
rB = −2NBB + NBAD · CE (10)
rBA =
NBA
D
· CE (11)
rBB =
NBB
D
· CE (12)
rE = (−kinact,A · CA − kinact,B · CB − kinact,time) CE. (13)
For the ease of representation, the terms NBA, NBB, and D are defined as the following
constitutive equations:
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NBA = k22 · k33 · k4 · k5 · CA · CBB
− k2 · k3 · k44 · k55 · CB · CBA
+ k1 · (k22 + k3) · k4 · k5 · CA · CB
− k11 · (k22 + k3) · k44 · k55 · CBA, (14)
NBB = k2 · k3 · k44 · k55 · CB · CBA
− k22 · k33 · k4 · k5 · CA · CBB
+ k1 · k2 · k3 · (k44 + k5) · C2B
− k11 · k22 · k33 · (k44 + k5) · CBB, (15)
D = k11 · (k22 + k3) · (k44 + k5)
+ k1 · (k22 + k3) · k4 · CA · CB
+ (k22 + k3) · k4 · k55 · CA · CBA
+ k33 · k4 · (k22 + k5) · CA · CBB
+ k1 · k2 · (k44 + k5) · C2B
+ k2 · (k3 + k44) · k55 · CB · CBA
+ k2 · k33 · (k44 + k5) · CB · CBB
+ (k22 + k3) · k4 · k5 · CA
+ k1 · (k22 + k3) · (k44 + k5) · CB
+ k2 · k3 · (k44 + k5) · CB
+ (k11 + k44) · (k22 + k3) · k55 · CBA
+ (k11 + k22) · k33 · (k44 + k5) · CBB. (16)
Note that the original parameter values in [27] were not directly applicable as these parameters
were derived for a kinetic model without thermal Pf BAL inactivation. However, in this study, all kinetic
parameters in Equations (9)–(16) were estimated using the methods and data presented in [27] and are
summarized in Table 2.
3.1.3. Dynamic Optimization Problem and Solution Strategy
The dynamic optimization problem aimed to maximize the final concentration of BA with respect
to the time varying material balances, the volume change, and the reaction kinetic equations and is
defined for the various intensification cases as:
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maximize
jA(t), jB(t), CA0,
CB0, CE0, V0
CBA(tf) (17a)
subject to Material balances: Equations (1)− (7), (17b)
Volume change: Equation (8), (17c)
Reaction kinetics: Equations (9)− (16), (17d)
0 ≤ qi(t) ≤ 0.1 L min−1, for all i in {A, B}, (17e)
0 ≤ V0 ≤ 3× 10−2 L, (17f)
0 ≤ V(t) ≤ 3× 10−2 L, (17g)
0 ≤ Ci,0 ≤ CUBi,0 , for all i in {A, B, BB, E}, (17h)
0 ≤ Ci(t) ≤ CUBi , for all i in {A, B, BB, E}, (17i)
CUBA,0 = C
UB
A = 100 mmol L
−1, (17j)
CUBB,0 = C
UB
B = 149.35 mmol L
−1, (17k)
CUBBB,0 = C
UB
BB = 2.78 mmol L
−1, (17l)
CUBE,0 = C
UB
E =
50
MwtE
= 8.4862× 10−4 mmol L−1, (17m)
t f = 180 min, (17n)
The upper bounds on q(t) were set to 100 mL min−1, which was the maximum pumping rate
of the dosing pumps (Equation (17e)); those for V0 and V(t) were set to 3× 10−2 L, which was the
maximum volume of the reactor used in the experimental setup (Equations (17f) and (17g)).
The inequality constraints (Equations (17h) and (17i)) represent the bounds for the initial and time
varying concentrations Ci,0 and Ci(t), respectively. The corresponding upper bounds were set to their
respective maximum values used when estimating the kinetic parameters with CUBA of 100 mmol L
−1
and CUBE of 50 µg mL
−1, with MwtE = 58919 g/mol (Equations (17j) and (17m)). The upper bounds for
B and BB were set to their solubility limits (Equations (17k) and (17l)). Finally, the maximum reaction
time tf was set to 180 min for the experimental duration time.
The dynamic optimization problem (Equation (17)) was solved by using the direct simultaneous
approach, because of its ability to efficiently handle numerical instabilities and path constraints [29,30].
Specifically, the dynamic optimization problem for all cases was transcribed into algebraic equations
by using the method of orthogonal collocation on finite elements [31]. The resulting system of algebraic
equations falls into a class of optimization problems called nonlinear programming (NLP) [30].
The NLP was implemented in the MATLAB API for CasADi 3.4.0, a framework for automatic
differentiation and numerical optimization [32]. Furthermore, 50 finite elements and three collocation
points were used to discretize the dynamic optimization problems for all intensification cases
considered. The number of 50 finite elements selected was found to provide a good trade-off
between numerical accuracy and computational cost; while the three collocation points were chosen as
recommended in [30]. The resulting NLP was solved by using IPOPT, an interior point solver designed
for large scale NLPs [33], in combination with the sparse symmetric linear solver MA57 [34,35].
All computations were performed on a Linux computer running a CentOS 7 operating system with an
Intel(R) Core(TM) i7-4789 processor at 3.60 GHz and 16 GB RAM.
3.2. Experimental Setup
3.2.1. Materials
All chemicals used in this study were of analytical grade and used as purchased.
Benzoin (racemic), propanal, thiamine diphosphate (ThDP), and triethanolamine (TEA) were
purchased from Sigma Aldrich; acetonitrile (ACN), dimethyl sulfoxide (DMSO), and Bradford
reagent from Carl Roth GmbH + Co. KG; 3,5-dimethoxy-benzaldehyde (DMBA), benzaldehyde,
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and bovine serum albumin (BSA) from Thermo Fisher Scientific; and trichloroacetic acid (TCA)
from PanReac AppliChem. No further purification steps were performed before the experiment.
Pure (R)-2-hydroxy-1-phenylbutan-1-one was provided by the Institute of Bio- and Geosciences
at Forschungszentrum Jülich, Germany. Pf BAL was kindly provided by the Institute of Bio-
and Geosciences at Forschungszentrum Jülich as well; the His tagged enzyme was expressed in
Escherichia coli SG13009, subsequently purified via immobilized metal affinity chromatography on a
Ni-NTA-column, and finally desalted with size exclusion chromatography [36]. The pooled fractions
were diluted to a concentration of 1 mg mL−1 with a desalting buffer (10 mmol L−1 TEA, 2.5 mmol L−1
MgSO4, 0.5 mmol L−1 ThDP, adjusted to pH 7.5 with 1 mol L−1 HCl), lyophilized for several days,
and then kept at −20 ◦C in an airtight container.
3.2.2. Preparation of Pf BAL Solution
Before each experiment, the enzyme solution and the reactant solution were freshly prepared in
separate flasks. For the enzyme solution, the Pf BAL lyophilizate was added to 10–20 mL of a prepared
TEA buffer solution (50 mmol L−1 TEA, adjusted to pH 8.5 with 1 mol L−1 HCl) containing cofactors
(0.72 mmol L−1 ThDP and 3.56 mmol L−1 Mg2+). The Pf BAL concentration in the stock solution was
determined with a standard Bradford assay [37] using a Tecan Spark photometer. The enzyme stock
solution was appropriately diluted with 50 mmol L−1 TEA buffer solution containing cofactors to the
concentration desired for the specific reaction.
Pf BAL activity was measured via the Pf BAL catalyzed ligation of fluorescent DMBA to
(R)-3,3′,5,5′-tetramethoxy-benzoin, causing a decrease in fluorescence over time [38]. Three different
solutions with 70 % v/v TEA buffer with cofactors and 30 % v/v DMSO were prepared for the activity
test. Solution I was obtained by diluting the enzyme stock solution with TEA buffer with cofactors
and DMSO to a final Pf BAL concentration of 15 µg mL−1. For Solution II, 2 mmol L−1 DMBA was
dissolved, and Solution III remained without further additions. Four samples and four blanks were
prepared in a 96 well microtiter plate by mixing 20 µL of Solution I with 180 µL of either Solution II
or III. The plate was placed inside the preheated plate reader (Tecan Spark) at a temperature of 30 ◦C,
and the emission intensity at 460 nm with an excitation at 362 nm was measured in intervals of 5 s for
a total time of 90 s. The activity of Pf BAL was calculated with an existing calibration curve for the
fluorescence of DMBA at varying concentrations.
For the reactant solution, benzaldehyde and propanal were dissolved in DMSO. This step was
done immediately before starting the experiment to avoid losses of any volatile substances.
3.2.3. Progress Curve Experiments
The results of dynamic optimization for the intensification cases were experimentally reproduced
by performing progress curve experiments under the respective optimal conditions. The experiments
were conducted in a magnetically stirred glass cylinder, which was placed in a water bath for
temperature control at 30 ◦C. To minimize the evaporation of volatile Substances A and B during the
experimental procedure, a PTFE lid was placed inside the glass cylinder right above the fluid level.
Small holes in the PTFE lid gave access for the feeding tubes. The position of the lid was manually
adjusted to correct for volume changes caused by sampling and, to a lesser extent, dosing.
The reaction was initiated by pouring both solutions (9 mL of reactant solution and 21 mL of
enzyme solution) into the glass cylinder. The liquid was homogenized with the magnetic stirrer,
and the lid was placed into position. After 10 s, a 100 µL zero sample was taken from the mixture
and transferred to a 1.1 mL high performance liquid chromatography (HPLC) vial containing 50 µL
of 1.25 % TCA solution to quench the enzymatic reaction immediately. About 950 µL of ACN were
added to dilute the sample for the following analysis and to minimize the headspace inside the HPLC
vial. Samples were taken at 6 to 10 min intervals for the first hour. Then, the sampling frequency was
reduced to minimize the overall extraction of the reaction volume. All samples were prepared for
analysis in HPLC on the same day or stored in a freezer at −20 ◦C until further processing.
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In the case of the fed-batch experiments, two glass syringes were filled with A and B, respectively,
before the start of the experiment and positioned in high precision neMESYS 290N syringe pumps
(Cetoni GmbH, Korbussen). PTFE tubes connected to the syringes were threaded through the holes
of the PTFE lid into the reaction vessel and submerged in the reaction mixture. The feeding profile
obtained from the dynamic optimizations for both substrates was individually programmed via
the neMESYS UserInterface software. Dosings of A and B were initiated simultaneously with the
zero sample.
3.2.4. HPLC Analysis
All samples from the progress curve experiments were filtered through 0.2 µm PTFE syringe
filters and were subsequently analyzed in reversed phase chromatography (RP-HPLC). About 30 µL of
the sample volume were injected onto an RP8-column (LiChrospher 100 RP-8 (5 µm), Merck KGaA)
at 40 ◦C. The eluent was a mixture of ultrapure water and ACN with a flow rate of 1.2 mL min−1.
Initially, the eluent composition was 82 % v/v ultrapure water and 18 % v/v ACN. After 5.5 min,
the composition was gradually changed within 2 min to 100 % ACN and maintained for 1 min. Then,
the composition was gradually changed back to 82 % v/v ultrapure water and 18 % v/v ACN within
2 min. The column was then flushed for 3 min to conclude the method, with a total runtime of
13.5 min. Peaks of the individual compounds appeared after retention times of 6.1 min for B, 8.5 min
for BA, and 9.1 min for BB. HPLC calibration was performed using standard samples of B, BB, and BA
dissolved in 70 % v/v TEA buffer solution and 30 % v/v DMSO.
4. Conclusions
This contribution presents the elementary process functions (EPF) approach as a viable model
based tool for designing optimal operating conditions for enzyme catalyzed reactions. For Pf BAL
catalyzed cross-carboligation of benzaldehyde and propanal, the final concentration of the product
(R)-2-hydroxy-1-phenylbutan-1-one was chosen as the objective function to be optimized, and three
process intensification scenarios were evaluated making use of the EPF concept.
The best final product concentration was obtained when dosing both aldehyde substrates, leading
to a 13 % increase compared to the optimized batch case that was used as the reference scenario. It was
found that dosing propanal only served in replenishing the amount converted during the reaction so
that the concentration constantly stayed at the upper limit specified in the design space. In contrast,
dosing of benzaldehyde was found to be optimal when the concentration was set to a low initial value
and never reached higher than 0.81 mmol L−1. This strategy slowed down the Pf BAL inactivation
considerably, as well as the competing reaction to the byproduct benzoin. Although fed-batch processes
are widely used in cases where substrates inhibit or even inactivate enzymes, determining time
dependent dosing strategies is feasible only using model based approaches as presented. The value
of the model based design becomes even more significant for optimization problems where the
objective function is less intuitive than the product concentration. In the case of dosing propanal and
benzaldehyde simultaneously and the derived optimal feeding profiles, experimental data confirmed
the predicted results in the lab.
The apparatus independent EPF approach presented in this work could serve as a tool that enables
process engineers to design novel processes and reactors systematically for enzyme catalyzed reaction
systems in general. Additional reaction conditions, such as temperature, pH value, and composition of
the reaction medium, might be incorporated into the kinetic model and open up the possibility for
further improvements. Once the effects of protein engineering become tractable by appropriate
structure–function relations, EPF based optimization of biocatalytic reactions may contribute to
combining protein engineering and process systems engineering concepts [6,39].
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Abbreviations
Mwt molecular weight (g mol−1)
E. coli Escherichia coli
Pf BAL benzaldehyde lyase from Pseudomonas fluorescens
A propanal
ACN acetonitrile
B benzaldehyde
BA (R)-2-hydroxy-1-phenylbutan-1-one
BB (R)-benzoin
CSTR continuous stirred tank reactor
DMBA 3,5-dimethoxy-benzaldehyde
DMSO dimethyl sulfoxide
E enzyme
EPF elementary process functions
HPLC high performance liquid chromatography
HPP (R)-2-hydroxy-1-phenylpropanone
NLP nonlinear programming
PTFE polytetrafluoroethylene
RP-HPLC reversed phase chromatography
TEA triethanolamine
ThDP thiamine diphosphate
Indices, subscripts and superscripts
f final
i species or component index
0 initial
in inlet feed
UB upper bound
Latin symbols
C concentration (mmol L−1)
D denominator term for the reaction rate
j dosing flux (mmol min−1)
k reaction rate constant
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N numerator term for the reaction rate
q feeding rate (L min−1)
r reaction rate (mmol L−1 min−1)
s binary variable (−)
t reaction time (min−1)
V volume (L)
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